Oxford Cannabinoid Technologies Holdings Plc – LSE:OCTP.L

Oxford Cannabinoid Technologies Holdings stock price today

GBP 2.325
+2.21
+1921.74%
Financial Health
0
1
2
3
4
5
6
7
8
9

Oxford Cannabinoid Technologies Holdings stock price monthly change

-66.67%
month

Oxford Cannabinoid Technologies Holdings stock price quarterly change

-77.45%
quarter

Oxford Cannabinoid Technologies Holdings stock price yearly change

-89.55%
year

Oxford Cannabinoid Technologies Holdings key metrics

Market Cap
1.25M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
N/A
Revenue
N/A
EBITDA
-2.40M
Income
-7.94M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Oxford Cannabinoid Technologies Holdings stock price history

Oxford Cannabinoid Technologies Holdings stock forecast

Oxford Cannabinoid Technologies Holdings financial statements

Oxford Cannabinoid Technologies Holdings Plc (LSE:OCTP.L): Profit margin
Nov 2021 0 -1.01K
Oct 2022 0 -3.70M
Apr 2023 0 -2.23M
Oct 2023 0 -2M
Oxford Cannabinoid Technologies Holdings Plc (LSE:OCTP.L): Debt to assets
Nov 2021 12960638 573.60K 4.43%
Jul 2022 7426 1.27K 17.22%
Oct 2022 7426436 1.27M 17.22%
Oct 2023 2790000 840K 30.11%
Oxford Cannabinoid Technologies Holdings Plc (LSE:OCTP.L): Cash Flow
Nov 2021 -2.58K 35 -67
Oct 2022 -4.23K 0 0
Apr 2023 -2.63K 0 0
Oct 2023 -1.16K 0 0

Oxford Cannabinoid Technologies Holdings alternative data

Oxford Cannabinoid Technologies Holdings Plc (LSE:OCTP.L): Employee count
Aug 2023 7
Sep 2023 7
Oct 2023 7
Nov 2023 7
Dec 2023 7
Jan 2024 7
Feb 2024 7
Mar 2024 7
Apr 2024 7
May 2024 7
Jun 2024 7
Jul 2024 7

Oxford Cannabinoid Technologies Holdings other data

  • What's the price of Oxford Cannabinoid Technologies Holdings stock today?

    One share of Oxford Cannabinoid Technologies Holdings stock can currently be purchased for approximately $2.33.

  • When is Oxford Cannabinoid Technologies Holdings's next earnings date?

    Unfortunately, Oxford Cannabinoid Technologies Holdings's (OCTP.L) next earnings date is currently unknown.

  • Does Oxford Cannabinoid Technologies Holdings pay dividends?

    No, Oxford Cannabinoid Technologies Holdings does not pay dividends.

  • How much money does Oxford Cannabinoid Technologies Holdings make?

    Oxford Cannabinoid Technologies Holdings has a market capitalization of 1.25M.

  • What is Oxford Cannabinoid Technologies Holdings's stock symbol?

    Oxford Cannabinoid Technologies Holdings Plc is traded on the LSE under the ticker symbol "OCTP.L".

  • What is Oxford Cannabinoid Technologies Holdings's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Oxford Cannabinoid Technologies Holdings?

    Shares of Oxford Cannabinoid Technologies Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Oxford Cannabinoid Technologies Holdings have?

    As Jul 2024, Oxford Cannabinoid Technologies Holdings employs 7 workers.

  • When Oxford Cannabinoid Technologies Holdings went public?

    Oxford Cannabinoid Technologies Holdings Plc is publicly traded company for more then 4 years since IPO on 21 May 2021.

  • What is Oxford Cannabinoid Technologies Holdings's official website?

    The official website for Oxford Cannabinoid Technologies Holdings is oxcantech.com.

  • How can i contact Oxford Cannabinoid Technologies Holdings?

    Oxford Cannabinoid Technologies Holdings can be reached via phone at +44 20 3034 2820.

Oxford Cannabinoid Technologies Holdings company profile:

Oxford Cannabinoid Technologies Holdings Plc

oxcantech.com
Exchange:

LSE

Full time employees:

7

Industry:

Biotechnology

Sector:

Healthcare

Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate is OCT461201, a selective CB2 receptor agonist in solid oral dosage form that is in pre-clinical development for use in the treatment of IBS-associated visceral pain, as well as neuropathic pain conditions, including post herpetic neuralgia. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.

Maddox House
London, W1S 2PZ

:
ISIN: GB00BMVMRB86
: